What's Happening?
Jeffrey Gleason has joined Crowell & Moring as a partner in its health-care group, according to an announcement made by the firm. Gleason's practice will focus on health-care law, government investigations,
and complex business litigation. He is known for representing health insurers in multimillion-dollar disputes, which include cases involving fraud, federal and state Racketeer Influenced and Corrupt Organizations statutes, state consumer protection laws, the Employee Retirement Income Security Act, breach of contract, the No Surprises Act, and the False Claims Act. Prior to joining Crowell & Moring, Gleason was with Robins Kaplan LLP and spent four years as a trial attorney in the Civil Fraud Section of the U.S. Department of Justice.
Why It's Important?
Gleason's move to Crowell & Moring is significant for the health-care sector, particularly in the realm of litigation and government investigations. His expertise in handling complex disputes involving health insurers could lead to more robust legal strategies and outcomes for clients facing fraud and compliance issues. This transition may also influence the firm's capacity to handle high-stakes cases under federal and state laws, potentially affecting the legal landscape for health-care providers and insurers. Stakeholders in the health-care industry, including insurers and legal professionals, stand to benefit from Gleason's experience and strategic insights.
What's Next?
With Gleason's addition to Crowell & Moring, the firm is likely to enhance its focus on health-care litigation and government investigations. This could lead to an increase in the firm's involvement in high-profile cases, particularly those involving complex regulatory and compliance issues. The firm's clients may expect more comprehensive legal support in navigating disputes related to the No Surprises Act and the False Claims Act. As Gleason settles into his new role, the firm may also expand its client base and influence within the health-care sector.
Beyond the Headlines
Gleason's expertise in fraud and compliance could have broader implications for the health-care industry, particularly in terms of regulatory practices and enforcement. His background with the DOJ may provide Crowell & Moring with unique insights into government strategies and priorities, potentially shaping how health-care providers approach compliance and litigation. This could lead to a shift in how legal firms strategize around health-care law, emphasizing proactive measures and risk management.
